MX2011007522A - Methods for treating the dengue virus infection by vitamin d. - Google Patents

Methods for treating the dengue virus infection by vitamin d.

Info

Publication number
MX2011007522A
MX2011007522A MX2011007522A MX2011007522A MX2011007522A MX 2011007522 A MX2011007522 A MX 2011007522A MX 2011007522 A MX2011007522 A MX 2011007522A MX 2011007522 A MX2011007522 A MX 2011007522A MX 2011007522 A MX2011007522 A MX 2011007522A
Authority
MX
Mexico
Prior art keywords
denv
infection
dengue virus
vitamin
treating
Prior art date
Application number
MX2011007522A
Other languages
Spanish (es)
Other versions
MX360183B (en
Inventor
Rosa Maria Del Angel Nunez De Caceres
Henry Nelson Puerta Guardo
Original Assignee
Ct Investig Y Estudios Del Ipn
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ct Investig Y Estudios Del Ipn filed Critical Ct Investig Y Estudios Del Ipn
Priority to MX2011007522A priority Critical patent/MX360183B/en
Publication of MX2011007522A publication Critical patent/MX2011007522A/en
Publication of MX360183B publication Critical patent/MX360183B/en

Links

Classifications

    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

The present invention refers to a method for treating the infection specifically caused by dengue virus DENV in its 4 known serotypes by the administration of Vitamin D3 (VD3), due to its anti-DENV properties, and compounds analogues to VD3, the invention also referring to the pharmaceutical formulations anti-DENV containing vitamin VD3 as an active agent, these may be combined or not with further therapeutic agents; the invention also refers to the therapeutic doses of VD3 for inhibiting the incipient infection caused by the dengue virus, and for inhibiting the progression of said infection to severe forms, also being useful as a prophylactic treatment in populations susceptible to the infection by DENV.
MX2011007522A 2011-07-14 2011-07-14 Methods for treating the dengue virus infection by vitamin d. MX360183B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MX2011007522A MX360183B (en) 2011-07-14 2011-07-14 Methods for treating the dengue virus infection by vitamin d.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MX2011007522A MX360183B (en) 2011-07-14 2011-07-14 Methods for treating the dengue virus infection by vitamin d.

Publications (2)

Publication Number Publication Date
MX2011007522A true MX2011007522A (en) 2013-01-29
MX360183B MX360183B (en) 2018-10-16

Family

ID=48195095

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2011007522A MX360183B (en) 2011-07-14 2011-07-14 Methods for treating the dengue virus infection by vitamin d.

Country Status (1)

Country Link
MX (1) MX360183B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111346079A (en) * 2020-02-24 2020-06-30 南方医科大学 Bacterial DNA gyrase inhibitor BRD7716 as medicine for treating and/or preventing dengue virus infection and pharmaceutical application thereof

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111346079A (en) * 2020-02-24 2020-06-30 南方医科大学 Bacterial DNA gyrase inhibitor BRD7716 as medicine for treating and/or preventing dengue virus infection and pharmaceutical application thereof
CN111346079B (en) * 2020-02-24 2023-06-20 南方医科大学 Bacterial DNA gyrase inhibitor BRD7716 as medicament for treating and/or preventing dengue virus infection and pharmaceutical application thereof

Also Published As

Publication number Publication date
MX360183B (en) 2018-10-16

Similar Documents

Publication Publication Date Title
NZ629996A (en) 2’- substituted carba-nucleoside analogs for antiviral treatment
EA201490377A1 (en) TREATMENT OF MULTIPLE SCLEROSIS BY COMBINATION OF LAKVINIMODE AND GLATIRAMER ACETATE
MX2013003634A (en) Polycyclic heterocycle derivatives and methods of use thereof for the treatment of viral diseases.
NZ703064A (en) Inhibitors of hepatitis c virus
WO2011127333A3 (en) Compounds for treating disease, for administering, and for pharmaceutical compositions
SG10201804552WA (en) Nanoparticle compositions, formulations thereof, and uses therefor
MY202109A (en) Viral replication inhibitors
MX339149B (en) Inhibitors of influenza viruses replication.
WO2013022846A3 (en) Flavonoid compounds
SG10201405826RA (en) Inhibitors of influenza viruses replication
MY197785A (en) Combinations of lsd1 inhibitors for the treatment of hematological malignancies
MX2013006846A (en) Inhibitors of influenza viruses replication.
EA201490254A1 (en) COMBINED TREATMENT OF HEPATITIS C
PH12015502230B1 (en) Novel viral replication inhibitors
MX350746B (en) Novel cyclosporin derivatives for the treatment and prevention of a viral infection.
JO3122B1 (en) Estra-1,3,5(10),16-tetraene-3-carboxamide derivatives, processes for their preparation, pharmaceutical preparations comprising them and their use for preparing medicaments
WO2011153458A3 (en) Compositions and methods for inhibition of or treatment of dengue virus infection
MX2019012375A (en) Lfa-1 inhibitor formulations.
MX2014011218A (en) Use of amphoteric surfactants for the prevention and treatment of pathogenic vaginal biofilms in vaginal infections.
WO2016030899A8 (en) Methods of treating amyotrophic lateral scleroses
EA201390844A1 (en) COMPLEX COMPOSITION CONTAINING LERCANIDIPINE HYDROCHLORIDE AND VALSARTAN AND METHOD FOR ITS PREPARATION
MX2016014740A (en) A method for treating movement disorders with befiradol.
MX360183B (en) Methods for treating the dengue virus infection by vitamin d.
WO2013038200A3 (en) Neurodevelopmental disorders
MX2016003763A (en) Laquinimod combination therapy for treatment of multiple sclerosis.

Legal Events

Date Code Title Description
FG Grant or registration